⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TNGX News
Tango Therapeutics, Inc.
Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
globenewswire.com
TNGX
Form 8-K/A
sec.gov
TNGX
Tango Therapeutics Announces Executive Chair Transition
globenewswire.com
TNGX
Form 8-K
sec.gov
TNGX
Form 8-K
sec.gov
TNGX
Tango Therapeutics Appoints Robert Azelby to Board of Directors
globenewswire.com
TNGX
Form 8-K
sec.gov
TNGX
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
globenewswire.com
TNGX
Tango Therapeutics Announces Proposed $500 Million Public Offering
globenewswire.com
TNGX
Form 8-K
sec.gov
TNGX